Atypical Antipsychotics in Improvement of Quality of Life in Bipolar Disorder

A 8-Week, Multicenter, Open-Label, Observational Study of Atypical Antipsychotics in Improvement of Quality of Life in Bipolar Disorder

The purpose of this study is to reassure the clinical study data on atypical antipsychotics effect on quality of life in Korean Bipolar patients.

Inclusion Criteria:

• The patient and the patient's legal representative (if any) must understand the nature of the study and must have given written consent.
• Meet DSM-IV-TR criteria for bipolar disorder (bipolar I disorder, bipolar II disorder) at the time of baseline.

Exclusion Criteria:

• Serious or unstable, medical illness. Subjects with chronic illness may be included but must be stable and otherwise physically healthy on the basis of a physical examination, medical history.
• Known intolerance for or lack of response to atypical antipsychotics , as judged by the investigator.